TOKYO/PARIS Shares in Renault recovered some lost ground on Tuesday after the French carmaker and its Japanese partner Nissan Motor rejected media reports that their alliance was in danger of being dissolved. | Video
PARIS Shares in Sanofi rose on Tuesday after the French drugmaker said it would focus on vaccines and treatments like its promising eczema medicine Dupixent to grow sales, in a business revamp seen as potentially leading to spin-offs.
PARIS Sanofi SA said on Monday it would end its research efforts in diabetes and cardiovascular diseases as part of a revamp that will narrow the number of its business units in the hope of bolstering growth and profit.
PARIS Sanofi's most senior strategy boss is set to leave by the end of the month, according to a memo seen by Reuters, in the first major management change under new chief executive Paul Hudson as he shakes up the firm's priorities.
FRANKFURT/PARIS Sanofi is considering a joint venture or outright sale among options for its consumer healthcare unit, sources told Reuters, as the French drugmaker prepares to present a new strategic plan next month.
PARIS Sanofi expressed confidence for the fourth quarter and confirmed its full-year objectives on Thursday after posting lower third-quarter sales, hit by a fall in revenue at its primary care and vaccines businesses.
PARIS A landmark French trial will from next week seek to settle one of the country's biggest pharmaceutical scandals, probing whether the company behind a weight-loss drug believed to have triggered killer side-effects covered up the risks.
PARIS, Sept 13 Parisian commuters faced travel
chaos on Friday as transport workers went on strike over plans
to reduce their retirement privileges in a challenge to
President Emmanuel Macron's pension reform plans.